Sysmex ADR Income from Continuous Operations 2016-2024 | SSMXY

Sysmex ADR income from continuous operations for the twelve months ending December 31, 2024 was $0.194B, a 30.15% decline year-over-year.

  • Sysmex ADR annual income from continuous operations for 2025 was $0.354B, a 7.27% increase from 2024.
  • Sysmex ADR annual income from continuous operations for 2024 was $0.33B, a 2.58% decline from 2023.
  • Sysmex ADR annual income from continuous operations for 2023 was $0.338B, a 13.74% decline from 2022.

Sysmex ADR Income from Continuous Operations 2016-2024 | SSMXY

  • Sysmex ADR annual income from continuous operations for 2025 was $0.354B, a 7.27% increase from 2024.
  • Sysmex ADR annual income from continuous operations for 2024 was $0.33B, a 2.58% decline from 2023.
  • Sysmex ADR annual income from continuous operations for 2023 was $0.338B, a 13.74% decline from 2022.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185.9B
Thermo Fisher Scientific (TMO)$156.6B
Edwards Lifesciences (EW)$44.9B
Alcon (ALC)$43.1B
IDEXX Laboratories (IDXX)$41.4B
DexCom (DXCM)$32.9B
IQVIA Holdings (IQV)$27.8B
Mettler-Toledo (MTD)$24.8B
STERIS (STE)$22.2B
SONOVA HOLDING (SONVY)$17.4B
Waters (WAT)$17.1B
Hologic (HOLX)$14.3B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.4B
Globus Medical (GMED)$7.6B
Glaukos (GKOS)$5.6B
Teleflex (TFX)$4.9B
Integer Holdings (ITGR)$3.9B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.3B
Elekta AB (EKTAY)$1.9B
Nihon Kohden (NHNKY)$1.9B
Veracyte (VCYT)$1.8B
Alphatec Holdings (ATEC)$1.5B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B
Tandem Diabetes Care (TNDM)$984M